Europos Sąjunga - maltiečių - EMA (European Medicines Agency)

teva b.v. - zoledronic acid - osteoporosis; osteitis deformans; osteoporosis, postmenopausal - drogi għat-trattament ta 'mard tal-għadam - treatment of osteoporosis: , in post-menopausal women;, in men; , at increased risk of fracture including those with a recent low-trauma hip fracture. treatment of osteoporosis associated with long-term systemic glucocorticoid therapy: , in post-menopausal women;, in men; , at increased risk of fracture. it-trattament tal-marda ta'paget ta ' l-għadam fl-adulti.

Europos Sąjunga - maltiečių - EMA (European Medicines Agency)

novartis europharm limited  - voretigene neparvovec - leber congenital amaurosis; retinitis pigmentosa - other ophthalmologicals - luxturna huwa indikat għall-kura ta ' pazjenti adulti u pedjatriċi b'telf tal-vista minħabba ereditarju tar-retina distrofija kkawżati minn kkonfermat biallelic rpe65 mutazzjonijiet u li jkollu biżżejjed vijabbli tar-retina-ċelluli.

Europos Sąjunga - maltiečių - EMA (European Medicines Agency)

novartis europharm limited  - brolucizumab - deġenerazzjoni makulari mxarrba - oftalmoloġiċi - beovu huwa indikat fl-adulti għall-kura ta neovaskulari (imxarrba) relatata mal-età deġenerazzjoni makulari (amd).

Europos Sąjunga - maltiečių - EMA (European Medicines Agency)

samsung bioepis nl b.v. - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; myopia, degenerative - oftalmoloġiċi - byooviz is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv).

Europos Sąjunga - maltiečių - EMA (European Medicines Agency)

roche registration gmbh - faricimab - wet macular degeneration; macular edema; diabetes complications - oftalmoloġiċi - vabysmo is indicated for the treatment of adult patients with:neovascular (wet) age-related macular degeneration (namd),visual impairment due to diabetic macular oedema (dme).

Europos Sąjunga - maltiečių - EMA (European Medicines Agency)

viatris limited - aflibercept - macular edema; retinal vein occlusion; diabetic retinopathy; myopia, degenerative; diabetes complications - oftalmoloġiċi - yesafili is indicated for adults for the treatment ofneovascular (wet) age-related macular degeneration (amd) (see section 5. 1),visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo) (see section 5. 1),visual impairment due to diabetic macular oedema (dme) (see section 5. 1),visual impairment due to myopic choroidal neovascularisation (myopic cnv) (see section 5.

Europos Sąjunga - maltiečių - EMA (European Medicines Agency)

accord healthcare s.l.u. - ibandronic acid - wounds and injuries; breast diseases; neoplastic processes; calcium metabolism disorders; water-electrolyte imbalance - drogi għat-trattament ta 'mard tal-għadam - ibandronic acid huwa indikat fl-adulti forprevention ta ' episodji skeletriċi (fratturi patoloġiċi, komplikazzjonijiet fl-għadam li jeħtieġu r-radjuterapija jew il-kirurġija) f'pazjenti b'kanċer tas-sider u metastażi fl-għadam. trattament ta ' iperkalċemja kkawżata minn tumuri bi jew mingħajr metastażi. it-trattament ta'l-osteoporożi f'nisa wara l-menopawża f'riskju miżjud ta'ksur (ara sezzjoni 5. tnaqqis fir-riskju ta ' ksur vertebrali ġie muri, l-effikaċja fuq il-ksur fl-għonq tal-femora ma ġietx stabbilita.

Europos Sąjunga - maltiečių - EMA (European Medicines Agency)

sanquin plasma products b.v. - fattur tal-koagulazzjoni uman ix - hemofilja b - sustanzi kontra l-emorraġija - trattament u profilassi ta 'fsada f'pazjenti b'emofilja b (defiċjenza konġenitali tal-fattur ix).

Europos Sąjunga - maltiečių - EMA (European Medicines Agency)

amgen europe b.v. - denosumab - fractures, bone; neoplasm metastasis - drogi għat-trattament ta 'mard tal-għadam - prevenzjoni ta 'problemi skeletrali (ksur patoloġiku ta' l -, ir-radjazzjoni għall-għadam, kompressjoni tal-korda spinali jew kirurġija fl-għadam) f'adulti b'kanċer avvanzat li jinvolvi l-għadam (ara sezzjoni 5. it-trattament ta 'adulti u maturi skeletrali fl-adolexxenti bil-ġgant taċ-ċelluli tat-tumur ta' l-għadam li hija li ma jistgħax jitneħħa kirurġikament, jew fejn l-risezzjoni kirurġika huwa probabbli li jirriżulta f'sever tal-morbidità. .

Europos Sąjunga - maltiečių - EMA (European Medicines Agency)

baxalta innovations gmbh - nonacog gamma - hemofilja b - sustanzi kontra l-emorraġija - trattament u profilassi ta 'fsada f'pazjenti b'emofilja b (defiċjenza konġenitali tal-fattur ix).